Method Validation for Anticomplementary Activity of Human Immunoglobulin Drugs

M. A. Krivykh; O. G. Kornilova; N. D. Bunyatyan; E. V. Paramonova; R. A. Volkova; O. V. Fadeikina

doi:10.1007/s11094-016-1503-1

Method Validation for Anticomplementary Activity of Human Immunoglobulin Drugs

Authors: Krivykh M.A.¹, Kornilova O.G.¹, Bunyatyan N.D.¹, Paramonova E.V.¹, Volkova R.A.¹, Fadeikina O.V.¹
Affiliations:
1. State Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
Issue: Vol 50, No 9 (2016)
Pages: 625-629
Section: Article
URL: https://journals.rcsi.science/0091-150X/article/view/244450
DOI: https://doi.org/10.1007/s11094-016-1503-1
ID: 244450

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract
About the authors
References
Statistics

Abstract

Amethod for determining anticomplementary activity of human immunoglobulin (Ig) preparations for i.v. administration by complement fixation test was validated for accuracy, precision (repeatability, intralaboratory precision), limit of quantitation (LOQ), linearity, and analytical domain. The method could be used for quality assessment using the “anticomplementary activity” as part of the pharmaceutical quality examination of human Ig preparations.